Discovery and Characterization of Ephrin B2 and EphB4 Dysregulation and Novel Mutations in Cerebral Cavernous Malformations: In Vitro and Patient-Derived Evidence of Ephrin-Mediated Endothelial Cell Pathophysiology
Julie Sesen(Boston Children's Hospital), Katie Fehnel(Boston Children's Hospital)
Cited by 4
Related Papers
Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
|PLoS ONE|2015|204
Dysregulation of the EphrinB2−EphB4 ratio in pediatric cerebral arteriovenous malformations is associated with endothelial cell dysfunction in vitro and functions as a novel noninvasive biomarker in patients
|Experimental & Molecular Medicine|2020|25
AZIN1 level is increased in medulloblastoma and correlates with c-Myc activity and tumor phenotype
|Journal of Experimental & Clinical Cancer Research|2025|2